Clal Insurance Enterprises Holdings
Clal Insurance Enterprises Holdings reported 215 stocks worth $22.2M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are VOO (13.8%), SPY (10.2%) and Teva Pharmaceutical Inds Ltd (6.2%). Compared with Q1 2026, the fund opened new positions in DELL, DRAM and AMKR, added to VOO, SPY and TSEM, trimmed ESLT, ENLT and WDC and sold out of RSP, SHLD and XLE.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  VOO Vanguard S&P 500 ETF | $3.1M | 13.8% | 4.5M | +782K (+21%) | 8 of 8 | |
| 2 |  SPY Spdr S&P 500 ETF TR | $2.3M | 10.2% | 3M | +1M (+52%) | 8 of 8 | |
| 3 | TEVA PHARMACEUTICAL INDS LTD | $1.4M | 6.2% | 40.6M | +2.1M (+6%) | 8 of 8 | |
| 4 |  ESLT Elbit Sys Ltd | $1.2M | 5.5% | 1.6M | −3,067 (−0%) | 8 of 8 | |
| 5 |  TSEM Tower Semiconductor Ltd | $1.2M | 5.4% | 4.7M | +686K (+17%) | 8 of 8 | |
| 6 |  ENLT Enlight Renewable Energy Ltd | $986K | 4.4% | 11.2M | −527K (−5%) | 8 of 8 | |
| 7 |  QQQM Invesco Nasdaq | $931K | 4.2% | 3.1M | +1.6M (+105%) | 8 of 8 | |
| 8 |  NVMI Nova Ltd | $651K | 2.9% | 1.2M | No change | 8 of 8 | |
| 9 |  SMH Vaneck ETF Trust | $521K | 2.4% | 795K | +225K (+39%) | 6 of 8 | |
| 10 |  EEM Ishares Msci Emerging | $343K | 1.5% | 5M | +570K (+13%) | 4 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 RSP Invesco Exchange Traded FD T | $319K | 1.7M |
 SHLD Global X Fds | $120K | 1.7M |
 XLE Select Sector Spdr TR | $54K | 880K |
 GLD Spdr Gold TR | $35K | 82K |
 NKE Nike Inc | $34K | 633K |
🔒 Free account: see all 19.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
 SEDG Solaredge Technologies Inc | Call | $58K | 176K | +4,500 |
TSEM Tower Semiconductor Ltd | Put | $13K | 5,000 | +5,000 |
 WDC Western Digital Corp | Put | $9K | 1,300 | −2,400 |
 OEF Ishares TR | Put | $7K | 5,500 | +5,500 |
TEVA PHARMACEUTICAL INDS LTD | Call | $6K | 13K | −16,020 |
🔒 Free account: see all 9.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Clal Insurance Enterprises Holdings 13F FAQ
What does Clal Insurance Enterprises Holdings own?
Clal Insurance Enterprises Holdings reported 215 stocks worth $22.2M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are VOO (13.8%), SPY (10.2%) and Teva Pharmaceutical Inds Ltd (6.2%). The table above lists every position in the filing (the top 10 without an account).
What did Clal Insurance Enterprises Holdings buy and sell in Q2 2026?
Compared with Q1 2026: 30 new positions, 42 added to, 91 trimmed and 19 sold out. New positions include DELL, DRAM and AMKR. It sold all of RSP, SHLD and XLE.
When will Clal Insurance Enterprises Holdings file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Clal Insurance Enterprises Holdings's portfolio worth?
The Q2 2026 filing reports $22.2M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.